Register Login

PTC THERAPEUTICS, INC. (PTCT)

Almstead Neil Gregory 🟡 adjusted position in 8.1K shares (2 derivative) of PTC THERAPEUTICS, INC. (PTCT) at $85.26 ($1.3M) Transaction Date: Jun 26, 2026 | Filing ID: 000019

Full text
Register to leave comments
  • News bot June 30, 2026, 10:31 p.m.

    🔍 Almstead Neil Gregory (Executive)

    Company: PTC THERAPEUTICS, INC. (PTCT)

    Report Date: 2026-06-26

    Transaction Summary:

    • Total transactions: 7
    • Derivative instruments: 2
    • Holdings reported: 1
    • Total shares acquired: 8,130
    • Total shares sold: 16,260
    • Total shares held: 2,737

    Detailed Transactions and Holdings:

    • Acquired 412 shares of Common Stock at $38.1 per share (Direct)
      Date: 2026-06-26 | Code: M | equity_swap_involved: 0 | shares_owned_after: 60,549.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 412 shares of Common Stock at $85.23 per share (Direct)
      Date: 2026-06-26 | Code: S | equity_swap_involved: 0 | shares_owned_after: 60,137.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Acquired 7,718 shares of Common Stock at $38.1 per share (Direct)
      Date: 2026-06-26 | Code: M | equity_swap_involved: 0 | shares_owned_after: 67,855.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 7,718 shares of Common Stock at $85.26 per share (Direct)
      Date: 2026-06-26 | Code: S | equity_swap_involved: 0 | shares_owned_after: 60,137.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-06-26 | Code: H | nature_of_ownership: By Spouse | shares_owned_after: 2,737.00
    • Sold 412 shares of Stock Option (Right to Buy) at $38.1 per share (Derivative)
      Date: 2026-06-26 | Code: M | Expires: 2032-01-06 | equity_swap_involved: 0 | shares_owned_after: 27,405.00 | transaction_form_type: 4 | Footnotes: F1, F4
    • Sold 7,718 shares of Stock Option (Right to Buy) at $38.1 per share (Derivative)
      Date: 2026-06-26 | Code: M | Expires: 2032-01-06 | equity_swap_involved: 0 | shares_owned_after: 19,687.00 | transaction_form_type: 4 | Footnotes: F1, F4

    Footnotes:

    • F1: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025.
    • F2: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $85.07 to $85.30 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
    • F3: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $85.00 to $85.75 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
    • F4: Currently exercisable.

Search

News categories